Skip to content Skip to footer
Subscribe Now
INSIGHTS+ TOP 20

Insights+: An Analysis of the Growth of Biopharma Companies in the Last 20 Years (2006-2025) 

Shots:  PharmaShots' latest report chronicles the transformation of the global biopharma industry from 2006–2025, highlighting how innovation, strategic M&A, AI adoption, and evolving commercialization strategies have reshaped the competitive landscape while companies navigated patent cliffs, pricing pressures, and shifting market dynamics.   The report tracks the rise and fall of leading biopharma companies over two decades driven by…
4 days ago

Read more

VIEWPOINTS

Redefining Asthma Care: Caterina Brindicci and James Teague on Breztri Aerosphere’s US Approval and the Future of Triple Therapy  

Shots  Breztri Aerosphere became the first and only fixed-dose triple-combination maintenance therapy approved in the US for asthma patients aged 12 years and older, expanding beyond COPD and reinforcing the role of single-inhaler triple therapy in advancing asthma care.  The approval strengthens AstraZeneca’s respiratory portfolio and long-term vision of transforming care beyond symptom control, with additional regulatory reviews…
July 6, 2026

Read more

PharmaShots Celebrates Blooming 4 Years of Accomplishments
Announcements

PharmaShots Celebrates Blooming 4 Years of Accomplishments

PharmaShots Team is pleased to announce the completion of our 4 years, PharmaShots commenced its journey on the path of delivering real-time concise news focused on the Global Healthcare and Life Sciences Industry With a flourishing completion of 4 years, PharmaShots is delighted to announce an upgraded App, Exclusive & Spotlight Interviews, and ThoughtSpot services, along with a launch…
July 25, 2022

Read more